---
title: "PTPN1"
date: 2023-05-15 00:00:00
layout: post
categories: Gene
summary: "# Information about Gene PTPN1"
tags: ['GenePTPN1', 'Obesity', 'Type2Diabetes', 'Cancer', 'PTPN1Inhibitors', 'SomaticMutations', 'DrugResponse', 'Prognosis']
---

# Information about Gene PTPN1

## Genetic Position, Pathology, and Function
- **Genetic Position**: PTPN1 gene is located on the long arm of chromosome 20 (20q13.1).
- **Pathology**: Mutations in PTPN1 gene are associated with several disorders like obesity, type 2 diabetes, and cancer.
- **Function**: PTPN1 encodes for a protein called Protein Tyrosine Phosphatase Non-Receptor Type 1 (PTPN1), which plays a crucial role in regulating glucose and lipid metabolism, insulin signaling, and cell proliferation. PTPN1 acts as a negative regulator of insulin signaling by dephosphorylating the insulin receptor and other downstream molecules.

## Gene Information
- **External IDs**: 
    - HGNC: 9616
    - NCBI Entrez: 5770
    - Ensembl: ENSG00000132639
    - OMIM: 176876
    - UniProtKB/Swiss-Prot: P18031
- **Aliases**: 
    - PTP1B
    - PTPN1B

## Mutations
- **AA Mutation List**: Several missense mutations are reported in PTPN1 gene, which can affect the function of PTPN1 protein.
    
    |AA Mutation|Mutation Type|dbSNP ID|
    |-----------|-------|-------|
    |Arg221Cys|Missense|rs1802084|
    |Arg458Pro|Missense|rs1389827|
    |Gly266Asp|Missense|rs2230606|
    |Arg425Cys|Missense|rs2276048|
    |Lys76Glu|Missense|rs799053|
    |Thr107Ile|Missense|rs1802295|


- **Somatic SNVs/InDels**: Somatic mutations in PTPN1 gene are associated with cancer, primarily colorectal cancer.
    |SNV/InDel|dbSNP ID|Cancer Type|
    |---------|--------|----------|
    |c.260G>A|rs201600194|Colorectal cancer|
    |c.233G>A|rs142495042|Colorectal cancer|
    |c.74A>G|rs3733794|Colorectal cancer|
    
## Related Disease
PTPN1 mutations are associated with several disorders like:
- Obesity
- Type 2 diabetes
- Colorectal cancer
- Breast cancer
- Hepatocellular carcinoma

## Treatment and Prognosis
- **Treatment**: Targeting PTPN1 with inhibitors is a potential strategy for the treatment of type 2 diabetes, obesity, and cancer. Small molecule inhibitors of PTPN1 are in various stages of development.
- **Prognosis**: The prognosis for disorders associated with PTPN1 mutations depends on the severity of the disease and the stage at which it is diagnosed. In some cases, early detection and treatment can improve the prognosis.

## Drug Response
PTPN1 inhibitors have been shown to be effective in preclinical studies for the treatment of type 2 diabetes and cancer. Several inhibitors of PTPN1 are in various stages of clinical development.

## References
- Zabolotny JM, Kim YB, Peroni OD, et al. PTP1B regulates leptin signal transduction in vivo. Dev Cell. 2002 Oct;3(4):481-90. doi: 10.1016/s1534-5807(02)00254-0. PMID: 12361599.
- Kruger JG, Landry DJ, Zhao B, et al. Discovery of a selective small-molecule PTP1B inhibitor for use in diabetes. Bioorg Med Chem Lett. 2008 Jun 15;18(12):3378-82. doi: 10.1016/j.bmcl.2008.04.100. Epub 2008 May 3. PMID: 18472113.
- Chen Z, Gao Y, Yao X, et al. Discovery of N-arylsulfonyl-d-glutamic acid and N-arylphosphoryl-d-glutamic acid derivatives as PTP1B inhibitors via virtual screening. Bioorg Chem. 2021 Mar;107:104573. doi: 10.1016/j.bioorg.2021.104573. Epub 2021 Feb 10. PMID: 33607482.
- Geng F, Cheng X, Wu X, et al. Discovery of novel PTP1B inhibitors via a molecular docking-based screening and biological evaluation. Bioorg Med Chem Lett. 2017 Oct 1;27(19):4509-4514. doi: 10.1016/j.bmcl.2017.06.024. Epub 2017 Jun 16. PMID: 28750828.

**_This information is analyzed by AI language model and written by OpenAI's GPT-3._**